Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

STRIDES PHARMA SCIENCE LIMITED Capital/Financing Update 2024

Sep 6, 2024

62616_rns_2024-09-06_8039ba0e-861f-4842-990b-68a95e035208.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [136 x 44] intentionally omitted <==

September 6, 2024

BSE Limited

Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai – 400 001

Scrip code: 532531

The National Stock Exchange of India Limited Exchange Plaza, Bandra-Kurla Complex Bandra (E) Mumbai - 400 051

Scrip code: STAR

Dear Madam/ Sir,

Sub: Update on partial redemption of Secured, Unlisted, Redeemable, Non-Convertible Debentures

Ref: Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

This has reference to the Secured, Unlisted, Redeemable, Non-Convertible Debentures having face value of Rs. 10 Lakhs each aggregating to Rs. 125 Crores issued by the Company on a private placement basis.

In this regard, we wish to inform you that the Company has partially redeemed NCDs aggregating to Rs. 74 Crores along with applicable coupon/ interest rate.

This is for your information and records.

Thanks & Regards, For Strides Pharma Science Limited,

MANJUL Digitally signed by MANJULA R A R Date: 2024.09.06 19:10:58 +05'30'

Manjula Ramamurthy Company Secretary ICSI Membership No. A30515

==> picture [500 x 51] intentionally omitted <==